|
18 Sep 2007 |
Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
|
|
14 Sep 2007 |
Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
|
|
13 Sep 2007 |
ATL1102 Phase IIa Multiple Sclerosis Trial Update
|
|
06 Sep 2007 |
MediGene Completes Patient Recruitment for Clinical Trial of Cancer-Killing Virus NV1020
|
|
04 Sep 2007 |
Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
|
|
01 Sep 2007 |
ATL1103 for Growth & Sight Disorders Project Update
|
|
31 Aug 2007 |
Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
|
|
30 Aug 2007 |
Lorus advances clinical development of GTI-2040 combined with Ara-c in acute myeloid leukemia
|
|
30 Aug 2007 |
Phase II Study of IMC-A12 for Advanced Prostate Cancer Commences Patient Enrollment
|
|
29 Aug 2007 |
Journal of American College of Cardiology Publishes Positive Findings on Generx Now in Phase 3 for Heart Disease
|
|
28 Aug 2007 |
Diamyd updates gene therapy program and outlines plans for Phase I clinical trial for treatment of cancer pain
|
|
28 Aug 2007 |
Geron Scientists and collaborators demonstrate human embryonic stem cell-derived cardiomyocytes improve heart function when transplanted after myocardial infarction
|
|
17 Aug 2007 |
Inovio Biomedical partner Tripep receives approval to initiate Phase I/II study of novel vaccine for hepatitis C virus
|
|
17 Aug 2007 |
Bioniche provides update on refractory bladder cancer trial
|
|
14 Aug 2007 |
Ophthotech raises $36 million; in-licenses two compounds for macular degeneration
|
|
14 Aug 2007 |
Pervasis Therapeutics Successfully Completes Enrollment for Vascugel(TM) Phase II Clinical Trials
|
|
11 Aug 2007 |
Proteo, Inc./Proteo Biotech AG - Minapharm/Rhein Minapharm Biogenetics SAE: Proteo Biotech, Germany and Minapharm, Egypt enter into development and license agreement for Elafin
|
|
10 Aug 2007 |
Tissera reports significant milestone achievement in its large animal diabetic model studies.
|
|
07 Aug 2007 |
Antisoma starts phase II trial of AS1411 in acute myeloid leukaemia
|
|
03 Aug 2007 |
Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
|
|
02 Aug 2007 |
OncoGenex Initiates Phase I Clinical Trial of OGX-427 in Cancer
|
|
01 Aug 2007 |
OncoGenex and Isis Report Encouraging Interim Phase II Data in Advanced Prostate Cancer, Affirm Phase III Clinical Trial Plans
|
|
31 Jul 2007 |
Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases
|
|
25 Jul 2007 |
Targeted Genetics' Inflammatory Arthritis Phase I/II Trial Placed on Clinical Hold
|
|
24 Jul 2007 |
Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Docetaxel trial
|
